Lynx1 Capital Management as of June 30, 2022
Portfolio Holdings for Lynx1 Capital Management
Lynx1 Capital Management holds 12 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bellus Health Com New | 22.3 | $26M | 2.8M | 9.24 | |
| Merus N V (MRUS) | 19.3 | $23M | 1.0M | 22.64 | |
| Kinnate Biopharma (KNTE) | 18.0 | $21M | 1.7M | 12.61 | |
| Alpine Immune Sciences (ALPN) | 14.0 | $16M | 1.9M | 8.51 | |
| Cymabay Therapeutics | 6.5 | $7.6M | 2.6M | 2.95 | |
| Pardes Biosciences | 5.7 | $6.7M | 2.2M | 3.07 | |
| Pieris Pharmaceuticals (PIRS) | 5.1 | $6.0M | 3.2M | 1.87 | |
| Immunic (IMUX) | 3.3 | $3.8M | 1.1M | 3.47 | |
| Aerovate Therapeutics (AVTE) | 2.6 | $3.0M | 192k | 15.63 | |
| Theseus Pharmaceuticals | 2.4 | $2.8M | 505k | 5.53 | |
| Passage Bio (PASG) | 0.8 | $995k | 421k | 2.36 | |
| Otonomy | 0.1 | $62k | 30k | 2.07 |
